Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00413660 · ClinicalTrials.gov registry record · Phase 2

Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis

A Phase 2 study of Arthritis, Rheumatoid, sponsored by Pfizer.

Completed
Registry status
Phase 2
Development phase
509
Enrollment target
20
Study locations

NCT00413660 is a Phase 2 study of Arthritis, Rheumatoid that has completed, run by Pfizer. The registered enrollment target is 509 participants, below the 622-participant average among 27 other Arthritis, Rheumatoid trials with a reported enrollment target (18% lower). The trial reports 20 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00413660, a Phase 2 study of Arthritis, Rheumatoid, has completed, sponsored by Pfizer.

COMPLETED
Registry status
Phase 2
Development phase
509 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to determine the effectiveness and safety, over 6 months, of 6 dose regimens of CP-690,550, combined with methotrexate, for the treatment of adults with active rheumatoid arthritis.

Conditions Studied

Arthritis, Rheumatoid

Interventions

  • DRUG CP-690,550

Study Locations (20)

Florida

  • Pfizer Investigational Site - DeBary
  • Pfizer Investigational Site - Lake Mary
  • Pfizer Investigational Site - Ocala
  • Pfizer Investigational Site - Orlando
  • Pfizer Investigational Site - Tampa
  • Pfizer Investigational Site - Zephyrhills

Illinois

  • Pfizer Investigational Site - Rockford
  • Pfizer Investigational Site - Rockford

New York

  • Pfizer Investigational Site - Albany
  • Pfizer Investigational Site - Binghamton

North Carolina

  • Pfizer Investigational Site - Charlotte
  • Pfizer Investigational Site - Raleigh

Arizona

  • Pfizer Investigational Site - Gilbert

Arkansas

  • Pfizer Investigational Site - Hot Springs

California

  • Pfizer Investigational Site - Upland

Colorado

  • Pfizer Investigational Site - Denver

Trial Details

FieldValue
Enrollment Target 509 participants
Start Date 2007-01
Est. Completion 2008-08
Phase Phase 2

Sponsor

Pfizer

1,845 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00413660

The ClinicalTrials.gov registry entry for NCT00413660 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 509 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 622-participant average among 27 other Arthritis, Rheumatoid trials with a reported enrollment target (18% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Arthritis, Rheumatoid appearing as the primary indexed condition, and to 1 intervention - of which CP-690,550 is the first listed.

NCT00413660 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Florida, Illinois, New York.

Frequently Asked Questions

What is clinical trial NCT00413660 about?

NCT00413660 is a clinical study titled "Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis". The purpose of this study is to determine the effectiveness and safety, over 6 months, of 6 dose regimens of CP-690,550, combined with methotrexate, for the treatment of adults with active rheumatoid arthritis.

What is the current status of trial NCT00413660?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 509 participants. The study started on 2007-01. Estimated completion is 2008-08.

What conditions does trial NCT00413660 study?

This clinical trial studies the following conditions: Arthritis, Rheumatoid.

What interventions are being tested in trial NCT00413660?

The interventions under investigation include: CP-690,550 (DRUG).

Who is sponsoring clinical trial NCT00413660?

This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00413660 being conducted?

This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Arthritis, Rheumatoid

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Arthritis, Rheumatoid

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.